Altered fractionation: limited by mucosal reactions? (Q33678509)

28 July 2017

1 reference

title

Altered fractionation: limited by mucosal reactions? (English)

1 reference

28 July 2017

3

Ang KK

1 reference

28 July 2017

Kaanders JH

1

1 reference

PubMed ID

10392810

28 July 2017

van der Kogel AJ

series ordinal

2

1 reference

28 July 2017

1 March 1999

1 reference

Radiotherapy and Oncology

28 July 2017

1 reference

28 July 2017

50

1 reference

28 July 2017

3

1 reference

28 July 2017

247-260

1 reference

The effect of small radiation doses per fraction on mouse lip mucosa assessed using the concept of partial tolerance.

28 July 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0167-8140%2899%2900012-2

7 January 2021

The kinetics and capacity of repair of sublethal damage in mouse lip mucosa during fractionated irradiations

1 reference

https://api.crossref.org/works/10.1016%2FS0167-8140%2899%2900012-2

7 January 2021

Repopulation kinetics in irradiated mouse lip mucosa: the relative importance of treatment protraction and time distribution of irradiations

1 reference

https://api.crossref.org/works/10.1016%2FS0167-8140%2899%2900012-2

7 January 2021

Accelerated radiation therapy for locally advanced squamous cell carcinomas of the oral cavity and oropharynx selected according to tumor cell kinetics--a phase II multicenter study

1 reference

https://api.crossref.org/works/10.1016%2FS0167-8140%2899%2900012-2

7 January 2021

Fractionation Scheme with Low Individual Doses in Irradiation of Carcinoma of the Mouth

1 reference

https://api.crossref.org/works/10.1016%2FS0167-8140%2899%2900012-2

7 January 2021

The effects of sucralfate suspension and diphenhydramine syrup plus kaolin-pectin on radiotherapy-induced mucositis

1 reference

https://api.crossref.org/works/10.1016%2FS0167-8140%2899%2900012-2

7 January 2021

Potential clinical impact of normal-tissue intrinsic radiosensitivity testing.

1 reference

https://api.crossref.org/works/10.1016%2FS0167-8140%2899%2900012-2

7 January 2021

Repair capacity and kinetics for human mucosa and epithelial tumors in the head and neck: clinical data on the effect of changing the time interval between multiple fractions per day in radiotherapy.

1 reference

https://api.crossref.org/works/10.1016%2FS0167-8140%2899%2900012-2

7 January 2021

Tumor response, mucosal reactions and late effects after conventional and hyperfractionated radiotherapy

1 reference

https://api.crossref.org/works/10.1016%2FS0167-8140%2899%2900012-2

7 January 2021

Very accelerated radiation therapy: preliminary results in locally unresectable head and neck carcinomas

1 reference

https://api.crossref.org/works/10.1016%2FS0167-8140%2899%2900012-2

7 January 2021

Radiotherapy of advanced laryngeal cancer using three small fractions daily

1 reference

https://api.crossref.org/works/10.1016%2FS0167-8140%2899%2900012-2

7 January 2021

Hyperfractionated irradiation with or without concurrent chemotherapy for locally advanced head and neck cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0167-8140%2899%2900012-2

7 January 2021

Evidence for acutely hypoxic cells in mouse tumours, and a possible mechanism of reoxygenation

1 reference

https://api.crossref.org/works/10.1016%2FS0167-8140%2899%2900012-2

7 January 2021

A Feasibility Study of Concomitant Boost Radiotherapy for Patients with Cancer of the Supraglottic Larynx

1 reference

https://api.crossref.org/works/10.1016%2FS0167-8140%2899%2900012-2

7 January 2021

ASTRO plenary: interfraction interval is a major determinant of late effects, with hyperfractionated radiation therapy of carcinomas of upper respiratory and digestive tracts: results from Radiation Therapy Oncology Group protocol 8313

1 reference

https://api.crossref.org/works/10.1016%2FS0167-8140%2899%2900012-2

7 January 2021

Split-course accelerated therapy in head and neck cancer: an analysis of toxicity

1 reference

https://api.crossref.org/works/10.1016%2FS0167-8140%2899%2900012-2

7 January 2021

Acute reaction parameters for human oropharyngeal mucosa

1 reference

https://api.crossref.org/works/10.1016%2FS0167-8140%2899%2900012-2

7 January 2021

Mucosal regeneration during radiotherapy

1 reference

https://api.crossref.org/works/10.1016%2FS0167-8140%2899%2900012-2

7 January 2021

A randomised multicentre trial of CHART versus conventional radiotherapy in head and neck cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0167-8140%2899%2900012-2

7 January 2021

Repopulation in mouse oral mucosa: treatment splits

1 reference

https://api.crossref.org/works/10.1016%2FS0167-8140%2899%2900012-2

7 January 2021

Capacity and kinetics of SLD repair in mouse tongue epithelium

1 reference

https://api.crossref.org/works/10.1016%2FS0167-8140%2899%2900012-2

7 January 2021

Accelerated repopulation of mouse tongue epithelium during fractionated irradiations or following single doses

1 reference

https://api.crossref.org/works/10.1016%2FS0167-8140%2899%2900012-2

7 January 2021

Repopulation response of mouse oral mucosa during unconventional radiotherapy protocols.

1 reference

https://api.crossref.org/works/10.1016%2FS0167-8140%2899%2900012-2

7 January 2021

Prevention of oral mucositis in radiation therapy: a controlled study with benzydamine hydrochloride rinse

1 reference

https://api.crossref.org/works/10.1016%2FS0167-8140%2899%2900012-2

7 January 2021

The efficacy of sucralfate suspension in the prevention of oral mucositis due to radiation therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0167-8140%2899%2900012-2

7 January 2021

Effects of sucralfate on mucositis during and following radiotherapy of malignancies in the head and neck region. A double-blind placebo-controlled study

1 reference

https://api.crossref.org/works/10.1016%2FS0167-8140%2899%2900012-2

7 January 2021

Randomized phase I/II trial of two variants of accelerated fractionated radiotherapy regimens for advanced head and neck cancer: results of RTOG 88-09.

1 reference

https://api.crossref.org/works/10.1016%2FS0167-8140%2899%2900012-2

7 January 2021

Hyperfractionated radiation in the treatment of squamous cell carcinomas of the head and neck: a comparison of two fractionation schedules

1 reference

https://api.crossref.org/works/10.1016%2FS0167-8140%2899%2900012-2

7 January 2021

Comparison between normal tissue reactions and local tumor control in head and neck cancer patients treated by definitive radiotherapy

1 reference

https://api.crossref.org/works/10.1016%2FS0167-8140%2899%2900012-2

7 January 2021

Accelerated fractionation radiation therapy for advanced squamous cell carcinoma of the head and neck

1 reference

https://api.crossref.org/works/10.1016%2FS0167-8140%2899%2900012-2

7 January 2021

Preliminary results in advanced head and neck cancer with radiotherapy by multiple fractions a day

1 reference

https://api.crossref.org/works/10.1016%2FS0167-8140%2899%2900012-2

7 January 2021

Concomitant boost radiotherapy for squamous carcinoma of the tonsillar fossa

1 reference

https://api.crossref.org/works/10.1016%2FS0167-8140%2899%2900012-2

7 January 2021

Effects of sucralfate on acute and late bowel discomfort following radiotherapy of pelvic cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0167-8140%2899%2900012-2

7 January 2021

Accelerated fractionation (AF) compared to conventional fractionation (CF) improves loco-regional control in the radiotherapy of advanced head and neck cancers: results of the EORTC 22851 randomized trial

1 reference

https://api.crossref.org/works/10.1016%2FS0167-8140%2899%2900012-2

7 January 2021

Hyperfractionation versus conventional fractionation in oropharyngeal carcinoma: final analysis of a randomized trial of the EORTC cooperative group of radiotherapy

1 reference

https://api.crossref.org/works/10.1016%2FS0167-8140%2899%2900012-2

7 January 2021

Discontinuous accelerated fractionation in the treatment of advanced head and neck neoplasms--a preliminary report

1 reference

https://api.crossref.org/works/10.1016%2FS0167-8140%2899%2900012-2

7 January 2021

A randomised trial of accelerated versus conventional radiotherapy in head and neck cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0167-8140%2899%2900012-2

7 January 2021

Concomitant boost technique using accelerated superfractionated radiation therapy for advanced squamous cell carcinoma of the head and neck

1 reference

https://api.crossref.org/works/10.1016%2FS0167-8140%2899%2900012-2

7 January 2021

Accelerated radiotherapy with carbogen and nicotinamide (ARCON) for laryngeal cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0167-8140%2899%2900012-2

7 January 2021

Radiotherapy with carbogen breathing and nicotinamide in head and neck cancer: feasibility and toxicity

1 reference

https://api.crossref.org/works/10.1016%2FS0167-8140%2899%2900012-2

7 January 2021

Accelerated fractionation radiotherapy for laryngeal cancer, acute, and late toxicity

1 reference

https://api.crossref.org/works/10.1016%2FS0167-8140%2899%2900012-2

7 January 2021

Biweekly dose escalation in curative accelerated hyperfractionation for advanced head and neck cancer: a feasibility study

1 reference

https://api.crossref.org/works/10.1016%2FS0167-8140%2899%2900012-2

7 January 2021

Radiation therapy for advanced (T3T4N0-N3M0) laryngeal carcinoma: the need for a change of strategy: a radiotherapeutic viewpoint

1 reference

https://api.crossref.org/works/10.1016%2FS0167-8140%2899%2900012-2

7 January 2021

Accelerated fractionation radiotherapy for advanced head and neck cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0167-8140%2899%2900012-2

7 January 2021

Corticosteroids and radiation mucositis in head and neck cancer. A double-blind placebo-controlled randomized trial

1 reference

https://api.crossref.org/works/10.1016%2FS0167-8140%2899%2900012-2

7 January 2021

Does sucralfate reduce the acute side-effects in head and neck cancer treated with radiotherapy? A double-blind randomized trial

1 reference

https://api.crossref.org/works/10.1016%2FS0167-8140%2899%2900012-2

7 January 2021

Multiple fractions in the treatment of head and neck cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0167-8140%2899%2900012-2

7 January 2021

Accelerated radiation therapy in the treatment of very advanced and inoperable head and neck cancers

1 reference

https://api.crossref.org/works/10.1016%2FS0167-8140%2899%2900012-2

7 January 2021

Randomized clinical trial on accelerated 7 days per week fractionation in radiotherapy for head and neck cancer. Preliminary report on acute toxicity

1 reference

https://api.crossref.org/works/10.1016%2FS0167-8140%2899%2900012-2

7 January 2021

Base-of-tongue carcinoma: treatment results using concomitant boost radiotherapy

1 reference

https://api.crossref.org/works/10.1016%2FS0167-8140%2899%2900012-2

7 January 2021

Sucralfate mouth washing in the prevention of radiation-induced mucositis: a placebo-controlled double-blind randomized study

1 reference

https://api.crossref.org/works/10.1016%2FS0167-8140%2899%2900012-2

7 January 2021

Hyperfractionated photon radiation therapy in the treatment of advanced squamous cell carcinoma of the oral cavity, pharynx, larynx, and sinuses, using radiation therapy as the only planned modality: (preliminary report) by the Radiation Therapy Onc

1 reference

https://api.crossref.org/works/10.1016%2FS0167-8140%2899%2900012-2

7 January 2021

Radiation therapy for advanced head and neck squamous cell carcinoma using twice-a-day fractionation. A long-term follow-up

1 reference

https://api.crossref.org/works/10.1016%2FS0167-8140%2899%2900012-2

7 January 2021

Sucralfate for radiation mucositis: results of a double-blind randomized trial

1 reference

https://api.crossref.org/works/10.1016%2FS0167-8140%2899%2900012-2

7 January 2021

Hyperfractionated radiotherapy in advanced squamous cell carcinoma of the head and neck

1 reference

https://api.crossref.org/works/10.1016%2FS0167-8140%2899%2900012-2

7 January 2021

Treatment of advanced head and neck cancer: Multiple daily dose fractionated radiation therapy and sequential multimodal treatment approach

1 reference

https://api.crossref.org/works/10.1016%2FS0167-8140%2899%2900012-2

7 January 2021

Accelerated fractionation in advanced head and neck cancer: results and analysis of late sequelae

1 reference

https://api.crossref.org/works/10.1016%2FS0167-8140%2899%2900012-2

7 January 2021

A randomized double-blind phase III study of nimorazole as a hypoxic radiosensitizer of primary radiotherapy in supraglottic larynx and pharynx carcinoma. Results of the Danish Head and Neck Cancer Study (DAHANCA) Protocol 5-85.

1 reference

https://api.crossref.org/works/10.1016%2FS0167-8140%2899%2900012-2

7 January 2021

Twice-a-day radiotherapy for squamous cell carcinoma of the head and neck: the University of Florida experience

1 reference

https://api.crossref.org/works/10.1016%2FS0167-8140%2899%2900012-2

7 January 2021

Radiotherapy with thrice-a-day fractionation in a short overall time: Clinical experiences

1 reference

https://api.crossref.org/works/10.1016%2FS0167-8140%2899%2900012-2

7 January 2021

Prospective randomized trial comparing hyperfractionated versus conventional radiotherapy in stages III and IV oropharyngeal carcinoma.

1 reference

https://api.crossref.org/works/10.1016%2FS0167-8140%2899%2900012-2

7 January 2021

Single fraction per day versus two fractions per day versus radiochemotherapy in the treatment of head and neck cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0167-8140%2899%2900012-2

7 January 2021

Estimation of repair parameters in mouse lip mucosa during continuous and fractionated low dose-rate irradiation

1 reference

https://api.crossref.org/works/10.1016%2FS0167-8140%2899%2900012-2

7 January 2021

Biological equivalance of low dose rate to multifractionated high dose rate irradiations: investigations in mouse lip mucosa

1 reference

https://api.crossref.org/works/10.1016%2FS0167-8140%2899%2900012-2

7 January 2021

Radiotherapy by several sessions a day

1 reference

https://api.crossref.org/works/10.1016%2FS0167-8140%2899%2900012-2

7 January 2021

The reduction of radiation mucositis by selective decontamination antibiotic pastilles: a placebo-controlled double-blind trial

1 reference

https://api.crossref.org/works/10.1016%2FS0167-8140%2899%2900012-2

7 January 2021

Early tumour response and treatment toxicity after hyperfractionated radiotherapy in nasopharyngeal carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS0167-8140%2899%2900012-2

7 January 2021

Time-dose factors in radiotherapy: a review of the human data.

1 reference

https://api.crossref.org/works/10.1016%2FS0167-8140%2899%2900012-2

7 January 2021

The histological structure of some human lung cancers and the possible implications for radiotherapy

1 reference

https://api.crossref.org/works/10.1016%2FS0167-8140%2899%2900012-2

7 January 2021

How much could the radiotherapy dose be altered for individual patients based on a predictive assay of normal-tissue radiosensitivity?

1 reference

https://api.crossref.org/works/10.1016%2FS0167-8140%2899%2900012-2

7 January 2021

The feasibility of high-dose multiple daily fractionation and its combination with anoxic cell sensitizers in the treatment of head and neck cancer. A pilot study of the Radiotherapy Group of the EORTC (European Organisation for Research on Treatmen

1 reference

https://api.crossref.org/works/10.1016%2FS0167-8140%2899%2900012-2

7 January 2021

Radiotherapy by multiple fractions per day (MFD) in head and neck cancer: acute reactions of skin and mucosa

1 reference

https://api.crossref.org/works/10.1016%2FS0167-8140%2899%2900012-2

7 January 2021

Twice-a-day radiation therapy for cancer of the head and neck

1 reference

https://api.crossref.org/works/10.1016%2FS0167-8140%2899%2900012-2

7 January 2021

Tolerance to accelerated fractionation in the head and neck region

1 reference

https://api.crossref.org/works/10.1016%2FS0167-8140%2899%2900012-2

7 January 2021

10.1016/S0167-8140(99)00012-2

Identifiers

DOI

1 reference

28 July 2017

1 reference

PubMed ID

10392810